Scott Isom
-
- Diabetes Management and Research 24
- Diabetes Treatment and Management 11
- Diabetes, Cardiovascular Risks, and Lipoproteins 9
- Genetics top 2%
- Diabetes and associated disorders 19
- Pharmacy top 1%
- Speech and Hearing top 2%
-
- Acute Myeloid Leukemia Research 18
-
- Brain Metastases and Treatment 11
-
- Histone Deacetylase Inhibitors Research 9
-
- Cancer, Hypoxia, and Metabolism 9
- Co-authors
- Dana DabeleaLawrence M. DolanCatherine PihokerJasmin DiversJean M. LawrenceSharon SaydahSantica M. MarcovinaGiuseppina Imperatore
- Partner nations
- United StatesIndiaGermany
In The Last Decade
Scott Isom
128 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Endocrinology, Diabetes and Metabolism 1.8k
- Genetics 949
- Pharmacy 166
- Radiological and Ultrasound Technology 144
- Speech and Hearing 170
Countries citing papers authored by Scott Isom
This map shows the geographic impact of Scott Isom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Isom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Isom more than expected).
Fields of papers citing papers by Scott Isom
This network shows the impact of papers produced by Scott Isom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Isom. The network helps show where Scott Isom may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott Isom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 28 | |
| 7 | 2022 | 18 | |
| 8 | 2021 | 14 | |
| 9 | 2020 | 10 | |
| 10 | 2020 | 27 | |
| 11 | 2019 | 22 | |
| 12 | 2018 | 80 | |
| 13 | 2018 | 24 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 12 | |
| 16 | 2014 | 91 | |
| 17 | 2013 | 30 | |
| 18 | 2010 | 32 | |
| 19 | 2010 | 85 | |
| 20 | 2009 | 37 |
About Scott Isom
Scott Isom is a scholar working on Endocrinology, Diabetes and Metabolism, Hematology, Geriatrics and Gerontology, Genetics and Pharmacy, having authored 133 papers that have together received 5.0k indexed citations. Recurring topics across this work include Diabetes Management and Research (24 papers), Diabetes and associated disorders (19 papers), Acute Myeloid Leukemia Research (18 papers), Brain Metastases and Treatment (11 papers), Diabetes Treatment and Management (11 papers), Histone Deacetylase Inhibitors Research (9 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.8k citations), Genetics (949 citations), Pharmacy (166 citations), Radiological and Ultrasound Technology (144 citations) and Speech and Hearing (170 citations). Scott Isom has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Dana Dabelea, Lawrence M. Dolan, Catherine Pihoker, Jasmin Divers, Jean M. Lawrence, Sharon Saydah, Santica M. Marcovina, Giuseppina Imperatore, Elizabeth J. Mayer‐Davis and David J. Pettitt. Their work appears in journals such as Blood, Pediatric Diabetes, Journal of Clinical Oncology, Diabetes Care and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.